Effectiveness of workplace rehabilitation interventions in the treatment of work-related upper extremity disorders: a systematic review (Q35783336)

10 August 2017

1 reference

title

Effectiveness of workplace rehabilitation interventions in the treatment of work-related upper extremity disorders: a systematic review (English)

1 reference

10 August 2017

Renee M Williams

1

1 reference

10 August 2017

Muriel G Westmorland

series ordinal

2

1 reference

10 August 2017

Gloria Schmuck

series ordinal

3

1 reference

10 August 2017

Joy C MacDermid

series ordinal

4

1 reference

10 August 2017

publication date

1 April 2004

1 reference

10 August 2017

published in

Journal of Hand Therapy

1 reference

10 August 2017

volume

17

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

267-273

1 reference

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

cDNA cloning of murine interleukin-HP1: homology with human interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Human B-cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Signaling mechanisms through gp130: a model of the cytokine system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Myeloma biology and therapy. Present status and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Localized mediastinal lymphnode hyperplasia resembling thymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

IgG1 plasmacytosis in interleukin 6 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Interleukin 6 is required for the development of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Cytokines in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14750708.1.2.267

21 January 2018

Identifiers

DOI

10.2217/14750708.1.2.267

1 reference

10 August 2017

1 reference